Project: Comprehensive Prediction of Allogeneic Immune Responses
| Acronym | ComPAIR (Reference Number: 11969) |
| Duration | 31/05/2018 |
| Project Topic | Our goal is the development of a personalized medicine diagnostic product for the stratification of patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). These patients are at risk to develop severe Graft-versus-Host Disease (GvHD) while Graft-versus-Leukemia (GvL) effects are desired. We will deliver an HLA peptidome biomarker predicting outcome after alloHSCT, a clinically relevant setting for which no commercial test is available. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 8 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Philochem AG | Coordinator | Switzerland |
| 2 | Genomatix | Partner | Germany |
| 3 | Westfalian Wilhelms-University Muenster - University Hospital - Department of Medicine A | Partner | Germany |